Clinical Trials Sponsored by Luxia Scientific

Total 2047 results

Boston Scientific Corporation

Completed

Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)

Sudden Cardiac Death

United States, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Austria, Italy
Boston Scientific Corporation

Active, not recruiting

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China

Cardiovascular Diseases

China
Boston Scientific Corporation

Completed

SpaceOAR System RWS in China

Localized T1-T2 Prostate Cancer

China
Boston Scientific Corporation

Active, not recruiting

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) (NECTAR-HF)

Heart Failure | Congestive Heart Failure

Spain, Netherlands, Germany, Italy, United Kingdom, Belgium, Czechia, France
Boston Scientific Corporation

Completed

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)

Atherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial Disease

United States, Belgium, Canada, Japan, Austria, New Zealand
Boston Scientific Corporation

Active, not recruiting

A RWS of the FARAPULSE in A Chinese Population With PAF

Paroxysmal Atrial Fibrillation

China
Boston Scientific Corporation

Active, not recruiting

POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART) (POLAR SMART)

Paroxysmal Atrial Fibrillation

Korea, Republic of, Japan
Boston Scientific Corporation

Active, not recruiting

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) (VERITAS)

Varicose Veins

United States
Boston Scientific Corporation

Active, not recruiting

An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients

Chinese Patients Treated With Agent DCB

Taiwan, Hong Kong, Singapore
Boston Scientific Corporation

Active, not recruiting

CHAMPION-AF Clinical Trial (CHAMPION-AF)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Denmark, Canada, Israel, United Kingdom, France, Belgium, Netherlands, Japan, Germany, Switzerland, Italy, Poland, Saudi Arabia, Spain
Boston Scientific Corporation

Completed

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma

United States
Boston Scientific Corporation

Active, not recruiting

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

Stroke

United States, Denmark, Germany, Netherlands, United Kingdom, Belgium, Canada, Czechia, Italy
Boston Scientific Corporation

Active, not recruiting

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Denmark
Boston Scientific Corporation

Active, not recruiting

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION)

Atrial Fibrillation

United States, Spain, Denmark, Australia, France, Germany, Italy, Poland, Belgium, Netherlands
Boston Scientific Corporation

Active, not recruiting

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation (ADVANTAGE AF)

Persistent Atrial Fibrillation

United States, Belgium, Canada, Spain
Boston Scientific Corporation

Completed

Multiple Cardiac Sensors for the Management of Heart Failure (MANAGE-HF)

Heart Failure, Congestive

United States, Germany, France
Boston Scientific Corporation

Completed

S-ICD® System Post Approval Study

Primary Prevention of Sudden Cardiac Arrest | Secondary Prevention of Sudden Cardiac Arrest

United States
Hipra Scientific, S.L.U

Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Influenza, Human | SARS CoV 2 Infection

Spain
Boston Scientific Corporation

Terminated

Tracking Renal Tumors After Cryoablation Evaluation (TRACE)

Kidney Neoplasms

United States
Boston Scientific Corporation

Completed

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, Coronary

United States
Boston Scientific Corporation

Terminated

Step and Walking Pattern From Cardiac Monitor Study (SWAN)

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Insertable Cardiac Monitor

United States
Boston Scientific Corporation

Completed

SpyGlass™ Discover Percutaneous

Pancreatic Diseases | Bile Duct Diseases | Bile Duct Obstruction

United States, Belgium, Italy, Canada, Germany, Hong Kong, India
Boston Scientific Corporation

Completed

AXIOS CHINA (E7148)

Pancreatic Pseudocyst and Walled-off Necrosis

China
Boston Scientific Corporation

Completed

Non-Complex Biliary Stones DSC vs ERC

Biliary Stones

United States, India, Thailand, Italy
Boston Scientific Corporation

Completed

ACURATE Prime XL Human Feasibility Study

Aortic Stenosis

Australia
Hipra Scientific, S.L.U

Completed

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain, Italy
Boston Scientific Corporation

Completed

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic (PREEMPT-HF)

Heart Failure | Cardiovascular Disease | Heart Disease | Defibrillators, Implantable | Cardiac Resynchronization Therapy | Monitoring, Physiologic

United States, Spain, United Kingdom, Netherlands, Hong Kong, Denmark, France, Ireland, Australia, Belgium, Canada, Germany, Italy
Boston Scientific Corporation

Terminated

A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Brain Neoplasms | Glioblastoma Multiforme

United States
Boston Scientific Corporation

Completed

FAST Feasibility Study

Coronary Artery Disease

Australia, Latvia, New Zealand
Boston Scientific Corporation

Completed

Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX)

Atrial Fibrillation

United States
Boston Scientific Corporation

Active, not recruiting

Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery (EMINENT)

Vascular Diseases | Arteriosclerosis | Arterial Occlusive Diseases | Atherosclerosis

Germany, Ireland, Belgium, United Kingdom, France, Switzerland, Spain, Austria, Italy, Netherlands
Boston Scientific Corporation

Withdrawn

Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine

Migraine

Denmark, Norway, United Kingdom
Boston Scientific Corporation

Completed

Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial

Chronic Pain

United States
Boston Scientific Corporation

Withdrawn

WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm (WATCH-Rhythm)

Persistent Atrial Fibrillation
Boston Scientific Corporation

Completed

Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience

Endoscopic Retrograde Cholangiopancreatography

United States, Netherlands
Boston Scientific Corporation

Completed

Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain

Pain | Low Back Pain | Leg Pain

United States
Boston Scientific Corporation

Completed

Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) (SMARTMSP)

Left Ventricular Dysfunction

United States
Boston Scientific Corporation

Completed

AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study

Walled Off Pancreatic Necrosis

United States
Boston Scientific Corporation

Completed

Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR

Cardiovascular Diseases

China
Boston Scientific Corporation

Withdrawn

Clinical Outcomes of IVUS-guided Stenting Using the Boston Scientific Vici® Venous Stent System in Treating Patients With Chronic Non-malignant Iliofemoral Vein Obstruction (APAC VICI)

Chronic Venous Disorder | Venous Outflow Obstruction | Systemic Vein Outflow of Iliofemoral Vein
Boston Scientific Corporation

Completed

Spy II Clinical Registry

Biliary Tract Diseases

United States, Germany, Belgium, Denmark, France, Italy
Boston Scientific Corporation

Completed

Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)

Peripheral Arterial Disease

Japan
Boston Scientific Corporation

Terminated

Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL) (Rezūm XL)

BPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

United States, Australia
Boston Scientific Corporation

Completed

Safety and Efficacy of Cryoablation for Metastatic Lung Tumors (ECLIPSE)

Metastatic Lung Cancer

United States, France
Boston Scientific Corporation

Completed

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Pain | Neoplasm Metastasis

United States, Canada, France
Boston Scientific Corporation

Completed

Initial Chronic Human Validation Study: Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System (Chronic II)

Ventricular Tachyarrhythmias

New Zealand
Boston Scientific Corporation

Completed

WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture (E7025)

Refractory Anastomotic Esophageal Strictures

Netherlands, Sweden, Brazil
Boston Scientific Corporation

Completed

Spinal Cord Stimulation for Low Back Pain

Chronic Pain

United States
Boston Scientific Corporation

Completed

Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter

Cardiac Arrhythmias

Canada
Boston Scientific Corporation

Completed

Uphold LITE Post-Market Surveillance Study (Uphold LITE)

Pelvic Organ Prolapse

United States

Clinical Trials Sponsored by Luxia Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations